{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:38:47Z","timestamp":1786649927913,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Hypofractionated radiation therapy after Breast Conserving Surgery in patients of early breast carcinoma results in equivalent clinical outcome but better cosmesis as compared to conventional therapy. In this study we have compared the dosimetry and clinical outcome between Hypofractionated and Conventional whole breast radiation followed by boost therapy after patients had undergone breast conserving surgery for early breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims and Objectives:<\/jats:title>\n                    <jats:p>1. Dosimetric analysis and toxicity assessment between conventional and Hypofractionated radiation therapy.<\/jats:p>\n                    <jats:p>2. Comparative analysis of late toxicity between two groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>In the department of Radiation Oncology in a Tertiary Care Hospital, 100 patients between the age group 65-75 years were selected as per inclusion criteria of the study and there were 60 patients in the conventional group and 40 in the hypofractionated group respectively. All the patients underwent treatment in Varian Truebeam Linear accelerator with appropriate radiation planning after undergoing Breast Conserving Surgery along with adjuvant chemotherapy when indicated.The conventional group received a dose of 50 Gy in 25# followed by boost of 10 Gy in 5 # and the hypofractionated arm received a dose of 42.5Gy in 16# followed by a boost of 12.5Gy in 5 # . The post-operative tumour cavity was irradiated along with axillary lymph nodes when indicated. All the patients in both arms were assessed for toxicity related to therapy and quality of life as per EORTC Q45 in 2 years following treatment completion. All statistical tests were done by SPSS version 23. Unpaired t-test was used for dosimetric comparison. Comparison of QOL and toxicity was done by Chi-square test respectively between two groups. A p-value of &lt; 0.05 was taken to be significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      At the end of 2 years, 54 patients in conventional group and 38 patients in hypofractionated group could be assessed respectively and rest in both groups had lost to follow-up due to logistical reasons. There was no significant difference in dosimetry between the two groups as per unpaired t-test (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value &gt;0.05). In terms of Quality of Life assessment in two years following the completion of therapy the conventional arm had more toxicity than hypofractionated arm as per Chi-square test (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value &lt;0.05). Chi-square test revealed patients who had conventional therapy had worse cosmetic outcome and increased incidence of myelotoxicity than in those who received hypofractionated therapy, both statistically significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value &lt; 0.05). There was no incidence of locoregional relapse in either groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Hypofractionated whole breast Radiation therapy followed by boost therapy with can result in less toxicity and thus better cosmetic outcome and almost equal dosimetric results compared to Conventional Radiotherapy in patients after breast conserving surgery, thus comparatively increasing their quality of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_2491_23","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T17:01:18Z","timestamp":1743699678000},"page":"118-123","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["An observational study comparing the dosimetry and clinical effects of conventional versus hypofractionated radiotherapy in elderly patients of early breast cancer"],"prefix":"10.4103","volume":"21","author":[{"given":"Bappaditya","family":"Chhatui","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Medical College, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niladri","family":"Roy","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Medical College, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinjini","family":"Chakrabarty","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Medical College, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alakananda","family":"Choudhury","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Medical College, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Ravy","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Medical College, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justice","family":"Mazumder","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Medical College, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharma","family":"Majhi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Medical College, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"R2-20250403","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3121\/cmr.1.4.309","article-title":"NSABP breast cancer clinical trials:recent results and future directions","volume":"1","author":"Mamounas","year":"2003","journal-title":"Clin Med Res"},{"key":"R3-20250403","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(08)70077-9","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer:a randomised trial","volume":"9","author":"Bentzen","year":"2008","journal-title":"Lancet Oncol"},{"key":"R4-20250403","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer:a randomised trial","volume":"371","author":"Bentzen","year":"2008","journal-title":"Lancet"},{"key":"R5-20250403","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4048\/jbc.2018.21.e44","article-title":"Korean Breast Cancer Society. Comparative study between sentinel lymph node biopsy and axillary dissection in patients with one or two lymph node metastases","volume":"21","author":"Lee","year":"2018","journal-title":"J Breast Cancer"},{"key":"R6-20250403","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1200\/JCO.21.00934","article-title":"Management of the axilla in early-stage breast cancer:Ontario health (cancer care ontario) and ASCO Guideline","volume":"39","author":"Brackstone","year":"2021","journal-title":"J Clin Oncol"},{"key":"R7-20250403","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000507040","article-title":"An update on regional nodal irradiation:Indication, target volume delineation, and radiotherapy techniques","volume":"15","author":"Duma","year":"2020","journal-title":"Breast Care (Basel)"},{"key":"R8-20250403"},{"key":"R9-20250403","doi-asserted-by":"crossref","first-page":"15168","DOI":"10.18632\/oncotarget.24586","article-title":"Outcome after neoadjuvant chemotherapy in elderly breast cancer patients - a pooled analysis of individual patient data from eight prospectively randomized controlled trials","volume":"9","author":"von Waldenfels","year":"2018","journal-title":"Oncotarget"},{"key":"R10-20250403","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3857\/roj.2022.00577","article-title":"Journey to hypofractionation in radiotherapy for breast cancer:critical reviews for recent updates","volume":"40","author":"Kim","year":"2022","journal-title":"Radiat Oncol J"},{"key":"R11-20250403","doi-asserted-by":"crossref","first-page":"101456","DOI":"10.1016\/j.tranon.2022.101456","article-title":"Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery:A systematic literature review","volume":"22","author":"Schmitt","year":"2022","journal-title":"Transl Oncol"},{"key":"R12-20250403","first-page":"e3516","article-title":"Hypofractionation radiotherapy vs. conventional fractionation for breast cancer:A comparative review of toxicity","volume":"10","author":"Youssef","year":"2018","journal-title":"Cureus"},{"key":"R13-20250403","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1200\/JCO.20.01363","article-title":"Danish Breast Cancer Group Radiation Therapy Committee. Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial:The DBCG HYPO Trial","volume":"38","author":"Offersen","year":"2020","journal-title":"J Clin Oncol"},{"key":"R14-20250403","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4329\/wjr.v2.i6.197","article-title":"Hypofractionated radiotherapy in the treatment of early breast cancer","volume":"2","author":"Plataniotis","year":"2010","journal-title":"World J Radiol"},{"issue":"Suppl 1","key":"R15-20250403","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.21037\/tcr.2019.09.20","article-title":"Hypofractionated radiotherapy for elderly breast cancer patients:from early stages disease to local palliation for unresectable disease","volume":"9","author":"Nair","year":"2020","journal-title":"Transl Cancer Res"},{"key":"R16-20250403","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijrobp.2013.11.232","article-title":"The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer:a prospective cohort study","volume":"88","author":"Warren","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-20250403","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1186\/1471-2407-14-711","article-title":"Factors modifying the risk for developing acute skin toxicity after whole-breast intensity modulated radiotherapy","volume":"14","author":"De Langhe","year":"2014","journal-title":"BMC Cancer"},{"key":"R18-20250403","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s00066-017-1257-z","article-title":"Occurrence of pneumonitis following radiotherapy of breast cancer - A prospective study","volume":"194","author":"Vasiljevic","year":"2018","journal-title":"Strahlenther Onkol"},{"key":"R19-20250403","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ijrobp.2013.03.014","article-title":"Radiation dose to the esophagus from breast cancer radiation therapy, 1943-1996:an international population-based study of 414 patients","volume":"86","author":"Lamart","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2491_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:59:58Z","timestamp":1786647598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2491_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_2491_23","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2023-11-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}